Key Market Indicators
Sales of Slovene analgesic medicines are expected to reach $20.5 million by 2026, up from $20 million in 2021. This represents an average annual growth rate of 0.6%. Since 2012, the Slovene market has grown by an average of 3.8% each year. In 2021, Slovenia was ranked 19th in the world, just behind Slovakia at $20 million. Spain, Canada and Italy ranked second, third and fourth, respectively.
